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ABSTRACT: Two new biflavanones (1 and 2), three new
bichalconoids (3−5), and 11 known flavonoid analogues (6−16)
were isolated from the stem bark extract (CH3OH−CH2Cl2, 7:3,
v/v) of Ochna holstii. The structures of the isolated metabolites
were elucidated by NMR spectroscopic and mass spectrometric
analyses. The crude extract and the isolated metabolites were
evaluated for antibacterial activity against Bacillus subtilis (Gram-
positive) and Escherichia coli (Gram-negative) as well as for
cytotoxicity against the MCF-7 human breast cancer cell line. The
crude extract and holstiinone A (1) exhibited moderate
antibacterial activity against B. subtilis with MIC values of 9.1
μg/mL and 14 μM, respectively. The crude extract and lophirone F
(14) showed cytotoxicity against MCF-7 with EC50 values of 11
μg/mL and 24 μM, respectively. The other isolated metabolites showed no significant antibacterial activities (MIC > 250 μM) and
cytotoxicities (EC50 ≥ 350 μM).
The genus Ochna (Ochnaceae) comprises about 86 speciesof evergreen trees or shrubs distributed in Madagascar
and in tropical Africa, Asia, and the America.1 Members of this
genus are used in traditional medicine to treat malaria,
diarrhea, and hemorrhoids, as well as microbial and helminthic
ailments.1,2 Many species from the genus Ochna are known to
metabolize biflavanones, chalcones, and related compounds3,4
which are reported to exhibit antimalarial and antibacterial
activity and cytotoxicity against cancer cells.3−8 In our
endeavor to search for bioactive natural products from
Tanzanian medicinal plants, we investigated extracts of O.
holstii. It is a shrub or a medium-sized tree up to 15 m high
occurring in Southern Asia, Republic of South Africa, Ethiopia,
Zimbabwe, Kenya, and Tanzania.9−11 The plant is locally
known as “mkumbi” in Tanzania. There is no ethnomedical
information reported for this plant species, apart from its use to
relinquish evil spirits from children. The crude extract of O.
holstii has been reported to exhibit anti-HIV and contraceptive
activities.12,13 Previous phytochemical investigations of O.
holstii revealed the presence of dimeric and monomeric
flavonoids.14 Herein, we evaluated the crude extract of the
stem bark of O. holstii and its isolated constituents (1−16) for
antibacterial activity against Bacillus subtilis and Escherichia coli
and for cytotoxicity against the MCF-7 human breast cancer
cell line.
■ RESULTS AND DISCUSSION
Systematic purification of the CH3OH−CH2Cl2 (7:3, v/v)
extract of the stem bark of O. holstii using silica gel 60 (230−
400 mesh) column chromatography, followed by gel filtration
on a Sephadex LH-20 column and preparative reverse-phase
HPLC, yielded five new metabolites (1−5) and 11 known
compounds (6−16) (Figures S1−S84, Supporting Informa-
tion). The structures of the isolated compounds were
elucidated by 1D and 2D NMR spectroscopic and mass
spectrometric analyses. The known compounds were identified
as ouratein D (6),15 isochamaejasmin A (7),16,17 7′,7″-di-O-
methylisochamaejasmin (8),18 campylospermone A (9),19
liquiritigeninyl-(1-3,II-3)-naringenin (10),8 isoliquitigenin
(11),20 terminalionone (12),21 flavumchalcone (13),22 lophir-
one F (14),23 2,3-dihydrocalodenin B (15),3 and calodenin B
(16),24,25 by comparison of their spectroscopic data with
reported data.
Compound 1 was isolated as a pale white solid and was
assigned the molecular formula C31H24O9 based on HRESIMS
([M + H]+ m/z 541.1487, calcd 541.1499, Figure S8,
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Supporting Information) and NMR data (Table 1, Figures S1−
S7, Supporting Information). It showed a specific rotation
[α]24D of −115 (c 0.013, CH3OH). The IR spectrum revealed
the presence of hydroxy (3396 cm−1) and aromatic CC
(1604, 1516, and 1453 cm−1) groups. UV absorption maxima
at 262 and 330 nm indicated the presence of a flavanone-type
structure.15,26
The 1H NMR spectrum (Table 1, Figure S1, Supporting
Information) of 1 suggested that the compound has four
distinct aromatic systems. Ring A1 contained an ABX spin
system resonating at δH 7.50 (H-5), 6.54 (H-6), and 6.45 (H-
8). The substitution pattern of ring A2 was deduced from the
coupling constant (4J6″,8″ = 2.4 Hz) of the protons at δH 6.12
(H-6″) and 6.16 (H-8″). Furthermore, compound 1 contained
two protons of a p-disubstituted aromatic system resonating at
δH 7.28 (H-2′/6′) and 6.76 (H-3′/5′) for ring B1 and at δH
7.25 (H-2‴/6‴) and 6.74 (H-3‴/5‴) for ring B2. In addition,
the 1H NMR spectrum displayed methoxy group protons at δH
3.77 (H3-11), two oxymethine protons at δH 5.62 (H-2) and
5.58 (H-2″), and two methine protons at δH 4.50 (H-3) and
4.46 (H-3″). The 2,3-relative configuration of compound 1
was determined via the 1H NMR coupling constants and
splitting patterns. The splitting patterns of the resonances
assigned to H-2 (d, J = 10.2 Hz), H-2″ (d, J = 10.0 Hz), H-3
(dd, J = 10.2, 7.8 Hz) and H-3″ (dd, J = 10.0, 7.8 Hz)
suggested rings C1 (H-2/H-3) and C2 (H-2″/H-3″) to have
trans-relative configurations. This conclusion is corroborated
by the observed 3J2,3 being larger than that (2.3 Hz) reported
by Rocha et al. for the 2,3-cis-configured analogues, but similar
to the 9.2 and 9.9 Hz reported for the trans relative configured
analogues.15 Protons H-3 and H-3″ showed 3J3,3″ = 7.8 Hz,
which is comparable to the 3J3,3″ = 8.5 Hz previously reported
Table 1. NMR Spectroscopic Data (500 MHz) for Holstiinone A (1) and Holstiinone B (2)
holstiinone A (methanol-d4) holstiinone B (CDCl3)
position δC, type δH (J in Hz) HMBC, H→C δC, type δH (J in Hz) HMBC, H→C
2 86.7, CH 5.62, d (10.2) C-2′/6′, C-3″, C-4, C-9 85.3, CH 5.66, d (10.1) C-3, C-3′, C-2″/6″, 4, 4′
3 60.4, CH 4.50, dd (10.2, 7.8) C-2′, C-4, C-4′, C-10 59.8, CH 4.49, dd (10.1, 8.2) C-3″, C-1″, C-2, C-4, C-4″
4 196.0, C 194.2, C
5 131.9, CH 7.50, d (8.2) C-4, C-7, C-9 131.1, CH 7.66, d (8.8) C-4, C-7, C-9
6 112.8, CH 6.54, dd (8.2, 2.4) C-7, C-8, C-10 111.0, CH 6.62, dd (8.8, 2.4) C-7, C-8, C-10
7 165.3, C 164.9, C
8 107.9, CH 6.45, d (2.4) C-7, C-9, C-10, C-6 105.1, CH 6.55, d (2.4) C-6, C-7, C-10
9 166.5, C 165.7, C
10 122.1, C 121.9, C
1′ 132.1, C 132.0, C
2′/6′ 129.3, CH 7.25, AA′ C-2″, C-3′/5′, C-4′ 128.2, CH 7.34, AA′ C-2, C-3′/5′, C-4′
3′/5′ 116.3, CH 6.76, XX′ C-2′/6′, C-1′, C-4′ 114.1, CH 6.85, XX′ C-2′/6′, C-4′, C-1′
4′ 158.7, C 159.7, C
2″ 86.4, CH 5.58, d (10.0) C-2‴/6‴, C-3″, C-4″, C-9″ 85.2, CH 5.74, d (10.1) C-2‴/6‴, C-9″, C-4″, C-3″
3″ 60.2, CH 4.46, dd (10.0, 7.8) C-2, C-2″, C-4, C-4″, C-1‴ 59.5, CH 4.45, dd (10.1, 8.2) C-2, C-3, C-4, C-4″, C-1‴
4″ 200.5, C 198.6, C
5″ 165.3, C 164.6, C
6″ 97.7, CH 6.12, d (2.4) C-7″, C-8″, C-10″ 96.9, CH 6.14, d (2.4) C-5″, C-10″, C-8″, C-7″
7″ 167.9, C 166.4, C
8″ 99.9, CH 6.16, d (2.4) C-6″, C-7″, C-10″ 99.1, CH 6.11, d (2.4) C-10″, C-6″, C-7″
9″ 166.9, C 165.1, C
10″ 109.7, C 108.8, C
1‴ 131.8, C 132.5, C
2‴/6‴ 129.5, CH 7.28, AA′ C-2, 3′/5′, C-4′ 128.7, CH 7.36, AA′ C-2″, C-4‴, C-3‴/5‴
3‴/5‴ 116.2, CH 6.74, XX′ C-2‴/6‴, C-4‴, C-1‴ 115.5, CH 7.79, XX′ C-2‴/6‴, C-1‴, C-4‴
4‴ 158.7, C 155.7, C
OCH3-11 56.2, CH 3.77, s C-7″ 55.8, CH3 3.76, s C-7
OCH3-11″ 55.4, CH3 3.79, s C-7″
OCH3-7‴ 55.8, CH3 3.78, s C-4‴
OH-5′ 11.9, s C-5′, C-6′, C-10′
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for the gauche conformation, but dissimilar to the 3J3,3″ = 12.0
Hz of the anti-oriented protons of structurally closely related
compounds.6 Based on this observation, 1 is proposed to
possess syn H-3/H-3″ geometry. The HMBC cross-peaks
(Table 1, Figure S5, Supporting Information) of H-11 (δH
3.77), H-6″ (δH 6.12), and H-8″ (δH 6.16) to C-7″ (δC167.9)
corroborated the location of the methoxy group at C-7″ of ring
A2. In addition, the HMBC cross-peaks of proton resonances at
δH 4.50 (H-3) to C-2″ (δC86.4), C-4 (δC 196.0), C-4″ (δC
200.5), and C-10 (δC 122.1) and those at δH 5.62 (H-2) to C-
3″ (δC 60.2), C-4 (δC 196.0), C-9 (δC 166.4), and C-2′/6′ (δC
129.5) established the C-3−C-3″ linkage of the two flavanone
units. Similar C-3−C-3″ linkages were previously reported
from other plant species including campylospermone B from
Campylospermum mannii,19 ouratein D from Ouratea spectabi-
lis,15 4,4,7-tri-O-methylisocapylospermone A from Ochna
serrulata,27 chamaejasmin from Ormocarpum kirkii,8 and
chamaejasmin D from Stellera chamaejasme.28 The NMR
spectroscopic data for compound 1 closely resembled those of
campylospermone B19 and liquiritigeninyl-(1-3,II-3)-naringe-
nin,8 but had a methoxy group resonating at δH 3.77 (H-11)
and attached to C-7″ (δC 167.9), indicated by the HMBC
cross-peak of H-11 (δH 3.77) with C-7″ (δC 167.9). The ECD
spectrum of 1 (Figure 1) showed a weak positive Cotton effect
for the π → π* transition at ca. 360 nm, a negative Cotton
effect for the n → π* transition at ca. 300 nm, and a negative
Cotton effect at ca. 210 nm for the 1La electronic transition,
which indicated a (2R) absolute configuration for each
flavanone moiety.15 The absolute configuration at C-3 was
determined based on the trans relative configurations of the
neighboring H-2 and H-3 protons. Based on the above




Compound 2 was isolated as a white solid. The molecular
formula C33H28O9 was assigned based on HRESIMS ([M +
H]+ m/z 569.1741, calcd 569.1812, Figure S16, Supporting
Information) and NMR data (Table 1, Figures S9−S15,
Supporting Information). It showed a specific rotation [α]24D
of −92 (c 0.013, CH3OH). IR spectroscopy indicated the
presence of hydroxy (3320 cm−1), conjugated carbonyl (1698
cm−1), and aromatic CC (1598 and 1515 cm−1) groups.
The UV spectrum showed absorption maxima at 258 and 340
nm, conforming the presence of a flavanone-type structure.26,29
The NMR spectroscopic data of 2 (Table 1, Figures S9−S15,
Supporting Information) are closely related to those of
compound 1. Compound 2 contained two additional methoxy
groups with protons resonating at δH 3.76 (δC55.8) and 3.78
(δC 55.8) and attached to C-7 (δC 165.1) and C-4‴ (δC
155.7), respectively. For compound 2, the attachments of the
three methoxy groups at rings A1, A2, and B2 were established
based on the HMBC cross-peaks (Figure S13, Supporting
Information) of H3-11 (δH 3.76) and H-5 (δH 7.66) to C-7 (δC
164.9); of H-11′ (δH 3.79), H-6″ (δH 6.14), and H-8″ (δH
6.11) to C-7″ (δC166.4); and of H-11″ (δH 3.78) and H-2‴/
6‴ (δH 7.36) to C-4‴ (δC155.7). The 2,3-relative configuration
of structure 2 was determined based on the 1H NMR coupling
constants and splitting patterns. The resonances assigned to H-
2 and H-2″ were doublets with a coupling constant of 10.2 Hz
each, indicating 2,3- and 2″,3″-trans relative configurations.
The ECD spectrum of 2 (Figure 1) closely resembled that of 1
and was thus compatible with a (2R,2″R,3S,3″S) absolute
configuration. Based on the above spectroscopic evidence, the
new compound holstiinone B (2) was characterized as
(2R,2″R,3S,3″S)-5″-hydroxy-2-(4′-hydroxyphenyl)-7,7″-dime-
thoxy-2″-(4‴-methoxyphenyl)-[3,3″-bichromane]-4,4″-dione.
It is a methoxy derivative of 1, which is in agreement with the
enzymatic O-methylation, typical of flavonoids, by O-methyl-
transferases.30
Compound 3 was obtained as a pale yellow amorphous solid
and was assigned the molecular formula C31H28O9 based on
HRESIMS ([M + Na]+ m/z 567.1634, calcd 567.1631 (Figure
S24, Supporting Information) and NMR data (Table 2, Figures
S17−S23, Supporting Information). It showed a specific
rotation [α]24D of −176.9 (c 0.23, CH3OH). IR absorptions
at 3305, 1700, and 1598 cm−1 indicated the presence of
hydroxy, conjugated carbonyl, and aromatic moieties,
respectively. The UV spectrum showed absorption maxima at
340 and 264 nm, corresponding to aromatic moieties of a
flavanone. The 1H NMR spectrum (Table 2; Figure S17,
Supporting Information) showed 10 distinct aromatic proton
signals. COSY and TOCSY correlations (Figures S19 and S23,
Supporting Information) corroborated the presence of two p-
disubstituted aromatic rings (A1 and B2), two ABX aromatic
ring systems (A2 and B1), and one tetrahydrofuran ring system,
reminiscent of flavumchalcone,22 the only difference being the
presence of a signal corresponding to a methoxy group, the
protons of which resonate at δH 3.28. The attachment of the
methoxy group to C-6″″ (δC 83.6) was established based on
the HMBC (Table 2, Figure S21, Supporting Information)
cross-peaks of H3-8 (δH 3.28) to C-6″″ (δC 83.6). Further
important HMBC cross-peaks that confirmed the molecular
framework included those supporting the assignment of the
tetrahydrofuran ring, namely, H-3″″ (δH 4.69) to C-6″″ (δC
83.6), C-1′ (δC 113.6), and C-5″″ (δC 81.3), H-2″/6″ (δH
6.94) to C-6″″ (δC 57.0), H-2″″ (δH 3.22) to C-4″″ (δC 58.5)
and C-7 (δC 204.5), and H-4″″ (δH 3.22) to C-1″ (δC 131.9),
C-1‴ (δC 117.5), and C-7 (δC 204.5). The placement of
protons in ring B1 and A1 was supported by the HMBC cross-
peak of H-6′ (δH 7.54) to C-7 (δC 204.5) and H-2/6 (δH 7.07)
to C-2″″ (δC 84.4), respectively. In addition, the protons of
rings A2 and B2 were assigned based on the HMBC cross-peak
of H-6‴ (δH 7.02) to C-5″″ (δC 81.3) and that of H-2″/6″ (δH
Figure 1. ECD spectra of holstiinone A (1, blue), holstiinone B (2,
red), holstiichalcone I (3, yellow), and holstiichalcone II (4, green) in
MeOH.
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6.94) to C-6″″ (δC 57.0), respectively (Table 2, Figure S21,
Supporting Information).
The protons belonging to the spin system of the
tetrahydrofuran ring were assigned based on the COSY and
TOCSY correlations (Figure S19 and S22, Supporting
Information) of H-2″″ (δH 5.27) to H-3″″ (δH 4.69), H-3″″
(δH 4.69) to H-4″″ (δH 3.22), and H-4″″ (δH 3.22) to H-5″″
(δH 5.12) and H-6″″ (δH 4.27). The relative configurations at
the carbon atoms of the tetrahydrofuran ring were assigned
based on the NOESY correlations (Figure 2) of H-2″″ (δH
5.27) and H-5″″ (δH 5.12), H-2″″ (δH 5.27) and H-3″″ (δH
4.69), H-5″″ (δH 5.12) and H-6‴ (δH 4.27), and H-4″″ (δH
3.22) with H-6″″ (δH4.27). Based on the above spectroscopic
data, the new compound, holstiichalcone I (3), was




attempts, no crystals suitable for X-ray crystallography to
determine the absolute configuration of 3 were obtained. The
ECD spectrum is shown in Figure 1. Similar structures have
previously been reported from various Ochna,27,31,32 Campy-
lospermum,22,33 and Lophira34,35 species, however without their
absolute configuration having been determined.
Compound 4 was isolated as a yellow solid and was assigned
the molecular formula C30H22O8 based on HRESIMS ([M +
H]+ m/z 511.1478, calcd 511.1393, Figure S32, Supporting
Information) and NMR data (Table 3, Figures S25−S31,
Supporting Information). It showed a specific rotation [α]24D
of −21 (c 0.013, CH3OH). IR vibrations at 3382 and 1604
cm−1 suggested the presence of hydroxy and CC groups,
respectively. The UV spectrum displayed absorption bands
centered at 368, 340, and 284 nm that were in agreement with
a chalcone skeleton.7 The 13C NMR spectrum (Table 3, Figure
S26, Supporting Information) showed only 15 instead of 30
resonances, revealing compound 4 to be a symmetric dimeric
molecule. The 1H NMR data (Table 3, Figures S25 and S27,
Supporting Information) indicated the presence of two distinct
ABX spin systems at δH 7.99 (H-6′/6″″), 6.42 (H-5′/5″″), and
6.30 (H-3′/3″″) and at 7.70 (H-4″/4″″′), 7.68 (H-6″/6″″′),
and 7.01 (H-3″/3′″″). In addition, trans olefinic protons
resonating at δH 7.88 (H-3/3‴) and 7.67 (H-2/2‴) suggested
the presence of a chalcone moiety. Furthermore, the 13C NMR
spectrum (Table 3, Figure S26, Supporting Information)
consisted of signals due to a carbonyl function at δC 193.6 (C-
1/1‴), three oxygenated aromatic carbons at δC 167.5 (C-2′/
2″″′), 166.4 (C-4′/4″″′), and 158.9 (C-2″/2″″′), and 11 other
sp2-hybridized carbons between 145.6 and 103.8 ppm. The
locations of the trans olefinic systems and the ABX spin
systems were corroborated by HMBC cross-peaks (Table 3,
Figure S29, Supporting Information) of H-6′/6″″′ (δH 7.99)
and H-3/3′″″ (δH 7.88) to C-1/1‴ (δC 193.6) and of H-2/2‴
(δH7.67) and H-3″/3′″″ (7.01) to C-1″/1″″′ (δC128.2). In
Table 2. NMR Spectroscopic Data (500 MHz, Methanol-d4)
for Holstiichalcone I (3)
position δC, type δH (J in Hz) HMBC, H→C
1 129.8, C
2/6 129.2, CH 7.07, AA′ C-2‴, C-4, C-1




3′ 103.7, CH 5.90, d (2.1) C-5′, C-1′, C-4′
4′ 166.6, C
5′ 110.4, CH 6.19, dd (8.8, 2.1) C-1′, C-3′, C-4′
6′ 134.3, CH 7.54, d (9.0) C-2′, C-4′, C-7
1″ 131.9, C
2″/6″ 128.9, CH 6.94, AA′ C-4″, C-6″″, C-1″




3‴ 103.9, CH 6.31, d (2.1) C-5‴, C-4‴, C-2‴
4‴ 159.4, C
5‴ 107.8, CH 6.26, dd (8.2, 2.1) C-1‴, C-3‴, C-4‴
6‴ 131.4, CH 7.02, d (8.2) C-2‴, C-4‴, C-5′‴
2″″ 84.4, CH 5.27, d (8.2) C-2, C-3″″, C-6, C-7
3″″ 52.9, CH 4.69, dd (8.2, 5.5) C-2″″, C-4″″, C-1′, C-7
4″″ 58.5, CH 3.22, ddd (9.2, 5.5,
5.4)
C-3″″, C-1″, C-5″″, C-6″″,
C-7
5″″ 81.3, CH 5.12, d (9.2) C-4″″, C-6‴, C-2‴
6″″ 83.6, CH 4.27, d (5.4) C-2″, C-3″″, C-4″″, C-5″″,
C-6″, C-8
7 204.5, C
8 57.0, CH 3.28, s C-6″″
Figure 2. Key NOE correlations allowing the determination of the relative configuration of the tetrahydrofuran ring of holstiichalcone I (3).
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addition, the HMBC cross-peaks of H-6′/6″″ (δH 7.99) to C-
1/1‴ (δC 193.6), C-4′/4″″ (δC 166.4), and C-2′/2″″ (δC
167.5) and of H-3/3‴ (δH 7.88) to C-1/1‴ (δC 193.6) and C-
4″/4″″ (δC 130.8) (Table 3, Figure S29, Supporting
Information) confirmed the connection of the ABX rings A1/
A2 and trans olefinic units to carbonyl groups. Furthermore,
the common HMBC cross-peak of H-3″/3′″″ (δH 7.01) and
H-2/2‴ (δH 7.67) to C-5″/5′″″ (δC 127.5) (Table 3, Figure
S29, Supporting Information) and H-3/3′″″ (δH 7.01) to C-
1″/1″″′ (δC128.2) supported the assignment of rings B1/B2.
Compound 4 exhibited optical activity because of its axis of
chirality (atropisomerism), supporting its dimeric nature,
which resembles previously reported dimeric chalco-
noids.7,36−39 The ECD spectrum (Figure 1) shows positive
Cotton effects at 204, 253, 293, and 436 nm and negative
Cotton effects at 230, 274, 320, and 373 nm. As there are no
published ECD spectra available for bichalcones with known
absolute configuration, the ECD of the related biflavones may
provide a handle on the structure determination of 4. Hence
the spectrum of 4 shows resemblance to the ECD spectrum of
(−)-(Sa)-agatisflavone,36 whereas little to none to that of
(−)-(Ra)-4′,4″,7,7″-tetra-O-methylcupressuflavone.40 Its neg-
ative specific rotation ([α]24D of −21) and negative Cotton
effects at 373 and 320 nm therefore suggest that 4 most likely
has an (Sa)-bichalcone unit and thus a P-configuration.
41,42
Based on the above spectroscopic features, the new compound
holstiichalcone II (4) was characterized as (−)-(Sa)-(2E,2‴E)-
3,3‴-(2″,2″″′-dihydroxy-[1,1‴-biphenyl]-3,3‴-diyl)bis[1-
(2′,4′-dihydroxyphenyl)prop-2-en-1-one]. Similar compounds
have been previously reported from Rhus pyroides.7
Compound 5 was isolated as a yellow solid and was assigned
the molecular formula C30H24O8 based on HRESIMS ([M +
H]+ m/z 513.1575, calcd 513.1549, Figure S40, Supporting
Information) and NMR data (Table 4, Figures S33−S39,
Supporting Information). IR absorptions at 3326 and 1709
cm−1 indicated the presence of hydroxy and conjugated
carbonyl moieties, respectively. IR absorptions at 1631 and
1506 cm−1 are typical of CC stretches. The UV spectrum
with absorption maxima centered at λmax 264, 320, and 346 nm
indicated the presence of a chalconoid skeleton.29,43 The 1H
NMR spectrum (Table 4, Figure S33, Supporting Information)
displayed signals of a p-disubstituted aromatic ring resonating
at δH 7.23 (H-3′″″/5′″″) and 6.89 (H-2″″′/6″″′), three sets of
ABX spin systems at 7.73 (H-6″″), 6.24 (H-3″″), and 6.26 (H-
5″″) for ring A, at δH 7.31 (H-2″), 7.00 (H-5″), and 7.46 (H-
6″) for ring B2, and at 7.91 (H-6′), 6.38 (H-5′), and 6.27 (H-
3′) for ring A2. The 1H NMR spectrum consisted also of
signals corresponding to trans-olefinic protons at δH 7.72 (H-
3) and 7.57 (H-2) and ethylene protons at δH 3.24 (H-2‴) and
3.00 (H-3‴), which are common features of chalcone and
dihydrochalcone moieties, respectively. The 13C NMR
spectrum (Table 4, Figure S34, Supporting Information) of
5 showed a total of 30 carbons comprising two carbonyl
carbons at δC 193.3 (C-1) and 205.3 (C-1‴), six oxygenated
aromatic carbons (167.6−145.7 ppm), 20 sp2-hybridized
carbons (144.9−103.7 ppm), and two methylene carbons at
δC 40.6 (C-2‴) and 31.0 (C-3‴). Analysis of the HMBC
Table 3. NMR Spectroscopic Data (500 MHz, Methanol-d4)
for Holstiichalcone II (4)
position δC, type δH (J in Hz) HMBC, H→C
1 193.6, C
2 118.7, CH 7.67, m C-1, C-5″, C-1′
3 145.6, CH 7.88, d (15.3) C-1, C-4″, C-6″
1′ 114.7, C
2′ 167.5, C
3′ 103.8, CH 6.30, d (2.3) C-1′, C-5′
4′ 166.4, C
5′ 109.2, CH 6.42, d (2.4) C-3′, C-1′
6′ 133.5, CH 7.99, d (8.8) C-1, C-2′, C-4′
1″ 128.2, C
2″ 158.9, C
3′’ 117.6, C 7.01, d (8.8) C-1″, C5′’
4″ 130.8, CH 7.70, m C-3, C-2″, C-6″
5′’ 127.5, C
6″ 133.8, CH 7.68, m C-2″, C-4″
1‴ 193.6, C
2‴ 118.7, CH 7.67, m C-1‴, C-4‴″, C-5′″″
3‴ 145.6, CH 6.42, d (15.3) C-1‴, C-4″″′, C-6″″′
1″″ 114.7, C
2″″ 167.5, C
3″″ 103.8, CH 6.30, d (2.3) C-1″″, C-5″″
4″″ 166.4, C
5″″ 109.2, CH 6.42, d (2.4) C-3″″, C-1″″
6″″ 133.5, CH C-1‴, C-2″″, C-4″″
1‴″ 128.2, C
2‴″ 158.9, C
3‴″ 117.6, C 7.01, d (8.8)
4‴″ 130.8, CH 7.70, m C-3‴, C-2″″′, C-6″″′
5‴″ 127.5, C
6‴″ 133.8, CH 7.68, m C-2″″′, C-4″″′
Table 4. NMR Spectroscopic Data (500 MHz, Methanol-d4)
for Holstiichalcone III (5)
position δC, type δH (J in Hz) HMBC, H→C
1 193.3, C
2 119.4, CH 7.57, d (15.4) C-2′, C-2 C-6′, C-1
3 144.9, CH 7.72, d (15.4) C-3, C-1′, C-1, C-4″
1′ 114.6, C
2′ 166.6, C,
3′ 103.8, CH 6.27, AA′ C-1′, C-5′
4′ 167.5, C
5′ 109.4, C 6.38, dd (8.8, 2.4)
6′ 133.4, CH 7.91, XX′ C-1, C-2′, C-4′
1″ 128.7, C
2″ 122.1, CH 7.31, d (2.4) C-6″, C-4″
3″ 145.7, C
4″ 153.3, C
5″ 118.5, CH 7.00 d (8.8) C-1″, C-3″
6″ 127.4, CH 7.46, dd (8.8, 2.4) C-2″, C-4″
1‴ 205.2, C
2‴ 40.6, CH2 3.24, t (7.6) C-1″″, C-4″″′, C-3‴, C-1‴
3‴ 31.0, CH2 3.00, t (7.6) C-3′″″/5′″″, C-2‴, C-1‴
1″″ 114.0, C
2″″ 166.4
3″″ 103.7, CH 6.24, d (2.4) C-1″″, C-5″″
4″″ 166.8, C
5″″ 109.3, CH 6.26, dd (8.8, 2.4) C-3″″, C-1‴
6″″ 133, CH 7.73, dd (8.8) C-2″″, C-2″″, C-1‴
1″″′ 157.6, C
2″″′/6″″′ 118.3, CH 6.89, d (8.6) C-3′″″/5′″″, C-1″″’, C-4″″’
3′″″/5′″″ 130.7, CH 7.23, d (8.6) C-2″″′/6″″′, C-1″″′, C-3‴
4″″′ 136.9, C
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(Figure S37, Supporting Information) cross-peaks of H-2‴ (δH
3.24), H-3‴ (δH 3.00), and H-6″″ (δH 7.73) to C-1‴ (δC,
205.2) and that of H-2‴ (δH 3.24), H-3‴ (δH 3.00), H-2″″′/
6″″′ (δH 6.89), and H-3′″″/5′″″ (δH 7.23) to C-1″″′ (δC
157.6) allowed the assignment of the dihydrochalcone moiety
possessing rings A and B. In addition, the HMBC cross-peaks
of H-3 (δH 7.72), H-2 (δH 7.57), and H-6′ (δH 7.91) to C-1
(δC 193.3) and that of H-5″ (δH 7.00) to C-1″ (δC 128.7) and
C-3″ (δC 145.7) and H-6″ (δH 7.46) to C-3 (δC 144.9) allowed
the assignment of the chalcone moiety possessing ring A2 and
ring B2. The NOESY correlation of H-2″ (δH 7.31) to H-2″″′/
6″″′ (δH 6.89) corroborated the connectivity of the chalcone
and dihydrochalcone moieties. Based on the above spectro-
scopic analyses, the new compound holstiichalcone III (5) was
characterized as (E)-1-(2′,4′-dihydroxyphenyl)-3-(3″-[4″″-
{1‴-(2″″,4″″-dihydroxyphenyl)-5′″″-oxopropyl}phenoxy]-4″-
hydroxyphenyl)prop-2′-en-1-one. Similar compounds consti-
tuting chalcone and dihydrochalcone moieties have been
reported from Rhus pyroides,7 Luxemburgia octandra,44 and
Schinopsis brasiliensis.45
In addition to the five new compounds, 11 known flavonoid
analogues, 6−16 (Figures S41−S84, Supporting Information),
were isolated from the stem bark of O. holstii. Previously
related secondary metabolites have also been reported from
t h e Th yme l a e a c e a e a n d An a c a r d i c e a e f am i -
lies.16,17,28,46−48,7,36,44,45,49 Such interfamily phytochemical
similarities are indicative of phylogenetic relationships and
imply that the plant families possess similar enzymatic systems.
The crude extract of the stem bark of O. holstii and its
constituents were evaluated for antibacterial activity against B.
subtilis (Gram-positive) and E. coli (Gram-negative), as well as
for cytotoxicity against the MCF-7 human breast cancer cell
line (Figures S85−S88, Table 5, Supporting Information). The
crude extract exhibited significant activity against B. subtilis
with an MIC value of 9.1 μg/mL. Holstiinone A (1) showed
moderate antibacterial activity (MIC = 14.0 μM), whereas the
other tested compounds showed no significant activity (MIC >
250 μM) against B. subtilis. Furthermore, none of the
investigated compounds showed substantial antibacterial
activity against E. coli. Antibacterial activity dose−response
curves for compounds 1, 5, 6, 8, 9, and 14 against Gram-
positive B. subtilis and that of compound 14 against Gram-
negative E. coli are summarized in Figure S87 (Supporting
Information). The compounds were also tested for cytotoxicity
against the MCF-7 human breast cancer cell lines. Most of
these did not show substantial cytotoxicity (EC50 ≥ 350 μM),
while the crude extract and lophirone F (14) exhibited
moderate cytotoxicity with EC50 values of 11 μg/mL and 24
μM, respectively (Figure S88, Supporting Information).
Previous pharmacological studies have indicated that biflava-
nones and chalconoids possess antibacterial,18 antimalarial,6,50
anti-inflammatory,15 cytotoxic,47 anti-HIV,51 and antifungal28
activities, indicating their broad spectrum of biomedical
potential, warranting further exploration of the genus Ochna
and the Ochnaceae family in general for drug discovery.
Antibacterial activity of compounds 1, 5, 6, 8, 9, and 14 against
Gram-positive B. subtilis and 14 against Gram-negative E. coli,
showing the EC50, EC90, and MIC values (in μM), is
summarized in Table S5 (Supporting Information).
In conclusion, five new natural products (1−5) were isolated
from the stem bark extract of O. holstii along with 11 known
compounds. The biflavanones (1, 2, 6−10) and bichalconoids
(3, 4, 5, 15, 16) isolated from this species are in line with the
richness of the Ochnaceae family in this type of compounds.
The compounds also highlight the chemotaxonomic relation-
ship of the Ochnaceae family with the Anacardiceae and
Thymelaeaceae families. Holstiinone A (1) and lophirone F
(14) exhibited moderate antibacterial activity against B. subtilis
and showed weak cytotoxicity against MCF-7, respectively.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Optical rotations were
determined using a 341 LC OROT polarimeter (589 nm, 24.0 °C).
ECD experiments were performed on a Jasco model J-810, Rev.1.00,
spectropolarimeter. UV spectra were obtained using CH3OH as the
solvent using a Shimadzu UV-1650PC UV/vis spectrophotometer.
Infrared (IR) spectra were recorded on a PerkinElmer Spectrum FT-
IR spectrometer using liquid samples. NMR spectra were acquired on
either a Bruker Avance NEO 500 MHz (TXO cryogenic probe) or a
600 MHz (TCI cryogenic probe) spectrometer and were processed
using the MestreNova (v14.0.0) software. Chemical shifts were
referenced to the carbon and residual proton signals of the deuterated
solvents (CD3CN δH 1.94 and δC 118.26, methanol-d4 δH 3.30 and δC
49.00, CDCl3 δH 7.26 and δC 77.16) as internal standard. Assignments
were based on 1H, 13C, COSY, HSQC, HMBC, TOCSY, and NOESY
NMR spectra. LC-ESIMS spectra were acquired on a Micromass GC-
TOF micromass spectrometer (Micromass, Wythenshawe, Waters,
Inc. UK), recorded on a direct inlet, with 70 eV ionization voltage.
Elution was performed with a gradient mobile phase (H2O−CH3CN,
95:05−5:95, v/v) with a run time of 4−10 min. HRESIMS spectra
were obtained with a Q-TOF-LC/MS spectrometer using a 2.1 × 30
mm 1.7 μm RPC18 and H2O−CH3CN gradient (5:95−95:5 in 0.2%
formic acid, v/v) at Sternhagen Analys Lab AB, Gothenburg, Sweden.
Thin layer chromatography (TLC) was performed on silica gel 60
F254 (Merck, Darmstadt, Germany) using precoated aluminum plates
to monitor isolation processes. Various appropriate solvent systems
were used to develop TLC plates, which were visualized under UV
light (254 and 366 nm) and spraying with an anisaldehyde reagent
(prepared by mixing 3.5 mL of 4-anisaldehyde with 2.5 mL of
concentrated H2SO4, 4 mL of glacial HOAc, and 90 mL of CH3OH)
followed by heating (80−100 °C). Column chromatography (CC)
was run on silica gel 60 (230−400 mesh). Gel filtration was
performed on Sephadex LH-20 (GE Healthcare). Preparative
reversed-phase HPLC was performed on an Interchim Ultra
Performance Flash Purification (PF-430) system using Interchim v
5.1d.02 software and an RP-C8 Kromasil column (250 mm × 25 mm,
5 μm).
Plant Material. The stem bark of Ochna holstii was collected in
April 2017 from the Mkwagulo and Mtakayo clans’ sacred forest
graveyards (6°24′51.918″ S; 38°40′19.308′′ E, altitude 78.80 m) in
Fukayosi Village, Bagamoyo District, Pwani Region in Tanzania. The
plant was identified and authenticated by F. M. Mbago, a senior
taxonomist of the herbarium at the Botany Department of the
University of Dar es Salaam, where a voucher specimen (FMM. 3809)
was deposited.
Extraction and Isolation. The air-dried and ground stem bark
(1.7 kg) of O. holstii was extracted with CH3OH−CH2Cl2 (7:3, v/v)
for 72 h at room temperature by percolation (3 × 3L) to yield a dark
brown crude extract (86 g) after evaporation in a rotary evaporator at
40 °C. A portion of the crude extract (63 g) was subjected to column
chromatography over silica gel 60 (400 g), and gravity elution was
performed with a mixture of isohexane containing increasing amounts
of EtOAc (0−100%), followed by 5% CH3OH in EtOAc. A total of
180 fractions were collected and combined to 20 fractions, F1−F20,
on the basis of TLC analyses. F1 was subjected to a Sephadex LH-20
column (CH3OH−CH2Cl2, 8:2) to afford white solids holstiinone B
(2, 8 mg) and ouratein D15 (6, 6 mg). F2 was subjected to silica gel
column chromatography (30% EtOAc in isohexane) followed by
purification on Sephadex LH-20 (CH3OH−CH2Cl2, 8:2) to give a
pale yellow solid, holstiinone A (1, 6 mg). F3 and F4 were further
combined and purified on Sephadex LH-20 (CH3OH−CH2Cl2, 1:1)
to afford isochamaejasmin A16,17 (7, 6 mg). Purification of F5 on
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Sephadex LH-20 (CH3OH) gave a yellow solid, calodenin B
24,25 (16,
50 mg). F6 and F7 were further combined and purified by a Sephadex
LH-20 column (CH3OH−CH2Cl2, 1:1) followed by preparative
HPLC (CH3OH−MeCN, 85:15, for 40 min, with a flow rate of 4
mL/min) to afford holstiichalcone I (3, 12 mg) and flavumchalcone
(13, 4 mg).22 F8 was purified with a Sephadex LH-20 column
(CH3OH) to afford a yellow solid, holstiichalcone II (4, 7 mg). F9
was subjected to silica gel column chromatography (EtOAc−
CH2Cl2,1:1) followed by repeated purification on Sephadex LH-20
(CH3OH−CH2Cl2, 8:2) to give a yellow solid, holstiichalcone III (5,
5 mg). F17 and F18 were combined and purified on a Sephadex LH-
20 column (CH3OH−CH2Cl2, 1:1) followed by silica gel column
chromatography (EtOAc−CH2Cl2, 1:1) to afford a yellow solid,
lophirone F23 (14, 40 mg), and dihydrocalodenin B3 (15, 14 mg).
Purification of F10 on a Sephadex LH-20 column (CH3OH) gave a
white solid, campylospermone A19 (9,15 mg). Purification of F11 by
preparative TLC (EtOAc−CH2Cl2, 30:70) afforded a white solid,
7,7″-di-O-methylchamaejasmin18 (8, 4 mg). F12 and F15 were
combined and purified on a Sephadex LH-20 column (CH3OH−
CH2Cl2, 1:1) followed by further purification by preparative HPLC
(H2O−CH3CN, 85:15, for 60 min at a flow rate of 4 mL/min) to give
liquiritigeninyl-(I-3,II-3)-naringenin8 (10, 4 mg). F16 was purified by
preparative TLC (CH3OH−CH2Cl2, 5:95) to give a white solid,
isoliquitigenin20 (11, 4 mg), and a yellow solid, terminalionone21 (12,
6 mg).
Holstiinone A (1): pale white, amorphous solid; [α]24D −115 (c
0.013, CH3OH); UV (CH3OH) λmax 330 and 262 nm; ECD (c 0.05,
CH3OH) λmax (Δε) 360 (6.0), 300 (−45.0), 210 (−50.0); IR νmax
3396, 1604, 1516, 1453, cm−1; 1H and 13C NMR see Table 1;
HRESIMS m/z 541.1487 [M + H]+ (calcd for C31H25O9, 541.1499).
Holstiinone B (2): white solid; [α]24D −92 (c 0.013, CH3OH); UV
(CH3OH) λmax 340 and 258 nm; ECD (c 0.05, CH3OH) λmax (Δε)
360 (6.0), 300 (−45.0), 210 (−50.0); IR νmax 3320, 1698, 1598,
11515, cm−1; 1H and 13C NMR data see Table 1; HRESIMS m/z
569.1741 [M + H]+ (calcd for C33H29O9, 569.1812).
Holstiichalcone I (3): yellow, amorphous solid; [α]24D −176.9 (c
0.23 CH3OH); UV CH3OH λmax 340 and 264 nm; ECD (c 0.013,
CH3OH) λmax (Δε) 224 (−47), 284 (−33), 361 (+4) nm; IR v max
3305, 1700, 1598, 1513, cm−1; 1H and 13C NMR see Table 2;
HRESIMS m/z 567.1634 [M + Na]+ (calcd for C31H28O9 567.1631).
Holstiichalcone II (4): yellow solid; [α]24D −21 (c 0.013, CH3OH);
UV CH3OH λmax 368, 340, and 284 nm; ECD (c 0.05, CH3OH) λmax
(Δε) 436 (−7), 373 (−6) 320 (−6.0), 293 (4.0), 274 (−4), 253
(5.0), 230 (−18), 204 (20); IR νmax 3382, 1604, 1554, 1515, 1444,
1363 cm−1; 1H and 13C NMR see Table 3; HRESIMS m/z 511.1478
[M + H]+ (calcd for C30H23O8, 511.1393).
Holstiichalcone III (5): yellow solid; UV CH3OH λmax 336, 320,
and 264 nm; IR νmax 3326, 1709, 1506, 1515 cm
−1; 1H and 13C NMR
data see Table 4; HRESIMS m/z 513.1575 [M + H]+ (calcd for
C30H25O8, 513.1549).
Antibacterial Assays. The antibacterial activity of the crude
extract and the isolated compounds was evaluated against two
bacterial strains, B. subtilis (Gram-positive) and E. coli (Gram-
negative). Each test sample was first dissolved at 10 mg/mL in 100%
DMSO and stored at −20 °C. The bacterial strains were cultured by
standard procedures as previously reported.52 Briefly, a culture of
bacterial cells was grown to optical density (OD) 600nm = 0.5, then
diluted (10×) with prewarmed medium. The substances to be tested
were added to culture medium for a final concentration of 30 μg/mL,
each at 100 μL in a 96-well microtiter plate, then incubated for 24 h at
37 °C without agitation. The cell viability was measured by a
resazurin-based assay as previously described.53 Subsequently, 12 μL
of AlamarBlue solution was added to each well and incubated at 37
°C continuously for 1 h. The fluorescence was measured using a
POLARstar Omega microplate reader from BMG Labtech with the
excitation filter set to 544 nm and emission filter to 590 nm.
Ampicillin, a standard antibiotic, was used as a positive control, while
DMSO, the solvent used to dissolve the test substances, was used as a
negative control. In order to prevent fluorescence bleed-through from
the resorufin dye, the assays performed in 384-well plates were set up
with an empty well in-between. Certain substances were checked for
possible fluorescent or fluorescence-quenching properties by adding
the substance after the culture was incubated with the resazurin dye
only. The results were then compared to the fluorescence values
obtained initially without the addition of the compound/extract. All
experiments were performed in triplicate. The test compound/
extracts that caused a reduction of fluorescence by at least 50%
relative to the solvent control in any of the species were followed up
by additional tests to accurately determine antibacterial activity.
Cytotoxicity Assay. MCF-7 cells were cultured in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal calf serum and
kept in exponential growth as described previously.54 Briefly, cells
were seeded in 96-well plates at a density of 5 × 103 per well allowing
continued exponential growth overnight.55 Stock solutions of the test
sample dissolved in DMSO were added for a final concentration of
0.3% v/v of the solvent in the culture medium. Cell viability was
assayed using PrestoBlue cell viability reagent (ThermoFisher)
according to the manufacturer’s instructions following 24 h of
incubation in the presence of the compounds/extracts. A POLARstar
Omega plate reader (BMG Lab Tech) was used to measure resorufin
fluorescence at 544 nm excitation/590 nm emission. The cells treated
only with DMSO were used as a negative control.55 Three
independent replicate experiments were used to calculate the EC50
value for each compound/extract using 2-fold serial dilution.
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corresponding NMReDATA56 for the new compounds 1−5,
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